MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 94 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $287,000 | -19.6% | 93,074 | +6.5% | 0.00% | -33.3% |
Q4 2016 | $357,000 | -39.6% | 87,386 | -6.1% | 0.00% | -25.0% |
Q3 2016 | $591,000 | +17.5% | 93,076 | -0.3% | 0.00% | 0.0% |
Q2 2016 | $503,000 | -33.7% | 93,344 | +2.9% | 0.00% | -33.3% |
Q1 2016 | $759,000 | +24.8% | 90,692 | +17.9% | 0.01% | +20.0% |
Q4 2015 | $608,000 | -4.3% | 76,905 | +3.1% | 0.01% | 0.0% |
Q3 2015 | $635,000 | -33.6% | 74,624 | -3.6% | 0.01% | -28.6% |
Q2 2015 | $957,000 | +8.5% | 77,426 | +4.3% | 0.01% | +16.7% |
Q1 2015 | $882,000 | +5.1% | 74,224 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $839,000 | +28.7% | 74,224 | 0.0% | 0.01% | +20.0% |
Q3 2014 | $652,000 | +20.5% | 74,224 | 0.0% | 0.01% | +25.0% |
Q2 2014 | $541,000 | +44.7% | 74,224 | 0.0% | 0.00% | +33.3% |
Q1 2014 | $374,000 | -5.6% | 74,224 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $396,000 | +40.4% | 74,224 | 0.0% | 0.00% | +50.0% |
Q3 2013 | $282,000 | -43.6% | 74,224 | 0.0% | 0.00% | -50.0% |
Q2 2013 | $500,000 | – | 74,224 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 2,244,080 | $12,096,000 | 4.51% |
ALTFEST L J & CO INC | 39,491 | $1,653,000 | 1.15% |
GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $446,000 | 0.44% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 9,074,557 | $48,912,000 | 0.40% |
Virtus ETF Advisers LLC | 87,477 | $472,000 | 0.35% |
Cannell & Co. | 1,614,678 | $8,703,000 | 0.32% |
Birchview Capital, LP | 44,000 | $237,000 | 0.17% |
STONERIDGE INVESTMENT PARTNERS LLC | 180,534 | $973,000 | 0.14% |
HighPoint Advisor Group LLC | 8,484 | $344,000 | 0.12% |
MARINER INVESTMENT GROUP LLC | 63,090 | $340,000 | 0.12% |